Bahaa Elgendy

20PUBLICATIONS
28CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesEconometric and statistical methodsGene and molecular therapyOrganometallic chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 25, 2026
Discovery of Imine-Modified Quinazolinyl Sulfonamides as Dual hCA IX/XII Inhibitors with Potent Antiproliferative Activity.

|May 18, 2026
Pharmacological rescue of mitochondrial dysfunction, neurite degeneration, and premature death of ALS and AD iPSC-derived neurons.

|Jan 15, 2026
Structural Pharmacology of Estrogen-Related Receptors.

Puhan Zhao, Hong Fang, Bahaa Elgendy

|Dec 23, 2025
Discovery of BE2012, a First-in-Class REV-ERBα/β Antagonist with Favorable Selectivity and Pharmacokinetics, and In Vivo Efficacy in Inducing Key Myogenic Factors for Muscle Repair upon Acute Muscle Injury.

Lingaiah Maram, Aurore-Cecile Valfort, Mohammad Homaidur Rahman

|Jul 18, 2025
Iodine-promoted oxidative cross-coupling for the synthesis of (E)-2-(3-oxo-3-phenylprop-1-en-1-yl)-3-phenylquinazolin-4(3H)-one via C-H activation: development of synthetic TLX agonists.

Lingaiah Maram, Puhan Zhao, Thomas Koelblen

|Feb 26, 2025
Advances in the Development of Mitochondrial Pyruvate Carrier Inhibitors for Therapeutic Applications.

Henry Politte, Lingaiah Maram, Bahaa Elgendy

Pageof 4

Frequent Collaborators

5 joint publications

Thomas P Burris

5 joint publications

Lamees Hegazy

3 joint publications

Lingaiah Maram

2 joint publications

Kristine Griffett